Company intelligence / Profile preview
Korea Vaccine
Ansan-si, Gyeonggi-do, South Koreakoreavaccine.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Korea Vaccine develops and manufactures vaccines for infectious diseases such as polio and influenza. Its products include inactivated poliovirus vaccine ("Kovax Polio PF Inj."), influenza vaccine ("Kovax Flu PF Inj."), and antivenom for snakebites ("Kovax Freeze-dried Agkistrodon Antivenom Inj."). These are approved for use in South Korea; clinical results are not detailed publicly but the products are commercially available.
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- VaccineBiologic
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Korea Vaccine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Korea Vaccine.